BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Deloitte
Harvard Business School
AstraZeneca
Federal Trade Commission
Daiichi Sankyo
Farmers Insurance
Novartis
Dow
Boehringer Ingelheim

Generated: January 22, 2018

DrugPatentWatch Database Preview

GLYBURIDE; METFORMIN HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for glyburide; metformin hydrochloride and what is the scope of glyburide; metformin hydrochloride patent protection?

Glyburide; metformin hydrochloride
is the generic ingredient in two branded drugs marketed by Bristol Myers Squibb, Actavis Elizabeth, Aurobindo Pharma, Heritage Pharms Inc, Impax Labs Inc, Teva, and Zydus Pharms Usa Inc, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Glyburide; metformin hydrochloride has thirty-nine patent family members in twenty-six countries.

There are twenty drug master file entries for glyburide; metformin hydrochloride. Twenty-two suppliers are listed for this compound.
Summary for GLYBURIDE; METFORMIN HYDROCHLORIDE
Pharmacology for GLYBURIDE; METFORMIN HYDROCHLORIDE

US Patents and Regulatory Information for GLYBURIDE; METFORMIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076821-002 Jan 27, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076345-002 Feb 18, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076731-003 Nov 19, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Heritage Pharms Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 079009-001 Jun 3, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076716-002 Jun 28, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb GLUCOVANCE glyburide; metformin hydrochloride TABLET;ORAL 021178-003 Jul 31, 2000 DISCN Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Zydus Pharms Usa Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 206748-002 Feb 29, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076731-001 Nov 19, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076821-001 Jan 27, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 077870-003 Nov 14, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for GLYBURIDE; METFORMIN HYDROCHLORIDE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
RE38629 Solid oral dosage form comprising a combination of metformin and glibenclamide ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for GLYBURIDE; METFORMIN HYDROCHLORIDE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Cerilliant
Express Scripts
Fish and Richardson
Mallinckrodt
Fuji
Farmers Insurance
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot